The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c- Abl tyrosine kinase activity

Genes and Development

Volumn 11, Issue 19, 1997, Pages 2456-2467

  Wen, Shih Te ^a   Van Etten, Richard A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bcr Abl; C Abl; Philadelphia chromosome; SH3 binding protein; Two hybrid system

Indexed keywords

ANTIOXIDANT; BINDING PROTEIN; GENE PRODUCT; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTO ONCOGENE; YEAST;

EID: 0030803669     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.19.2456     Document Type: Article

References (74)

1. Adzhubei, A.A. and M.J. Sternberg. 1993. Left-handed poly-proline II helices commonly occur in globular proteins. J. Mol. Biol. 229: 472-493.
2. Andreotti, A.H., S.C. Bunnell, S. Feng, L.J. Berg, and S.L. Schreiber. 1997. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 385: 93-97.
3. Chae, H.Z., K. Robison, L.B. Poole, G. Church, G. Storz, and S.G. Rhee. 1994a. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: Alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. 91: 7017-7021.
4. Chae, H.Z., T.B. Uhm, and S.G. Rhee. 1994b. Dimerization of thiol-specific antioxidant and the essential role of cystein 47. Proc. Natl. Acad. Sci. 91: 7022-7026.
5. Chien, C.-T., P.L. Bartel, R, Sternglanz, and S. Fields. 1991. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. 88: 9578-9582.
6. Cicchetti, P., B.J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257: 803-806.
7. Cooper, J.A. and A. MacAuley. 1988. Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation. Proc. Natl. Acad. Sci. 85: 4232-4236.
8. Dai, Z. and A.M. Pendergast. 1995. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes & Dev. 9: 2569-2582.
9. Daniel, R., Y. Cai, P.M.C. Wong, and S.-W. Chung. 1995. Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene 10: 1607-1614.
10. Dingwall, C. and R.A. Laskey. 1991. Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16: 478-481.
11. Feller, S.M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13: 2341-2351.
12. Feng, S., J.K. Chen, H. Yu, J.A. Simon, and S.L. Schreiber. 1994. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266: 1241-1247.
13. Fotedar, R., P. Fitzgerald, T. Rousselle, D. Cannella, M. Doree, H. Messier, and A. Fotedar. 1996. p21 contains independent binding sites for cyclin and cdk2: Both sites are required to inhibit cdk2 kinase activity. Oncogene 12: 2155-2164.
14. Franz, W.M., P. Berger, and J.Y.J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8: 137-147.
15. Gertler, F.B., K. Niebuhr, M. Reinhard, J. Wehland, and P. Soriano. 1996. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87: 227-239.
16. Gietz, D., A. St. Jean, R.A. Woods, and R.H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20: 1425-1427.
17. Goff, S.P., E. Gilboa, O.N. Witte, and D. Baltimore. 1980. Structure of the abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA. Cell 22: 777-785.
18. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase phosphatase that associates with cdk2. Cell 75: 791-803.
19. Hirai, H. and H.E. Varmus. 1990a. Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells. Proc. Natl. Acad. Sci. 87: 8592-8596.
20. _. 1990b. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol. Cell. Biol. 10: 1307-1318.
21. BCR/ABL is not required transformation of hematopoietic factor-dependent cells. Blood 86: 3897-3904.
22. Ishii, T., M. Yamada, H. Sato, M. Matsu, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai. 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
23. Ishii, T., T. Kawane, S. Taketani, and S. Bannai. 1995. Inhibition of the thiol-specific antioxidant activity of rat liver MSPZ3 protein by hemin. Biochem. Biophys. Res. Comm. 216: 970-975.
24. Iwahara, S., H. Satoh, D.X. Song, J. Webb, A.L. Burlingame, Y. Nagae, and U. Muller-Eberhard. 1995. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34: 13398-13406.
25. Jackson, P. and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the mynstoylated form of c-abl. EMBO J. 8: 449-456.
26. Jackson, P.K., M. Paskind, and D. Baltimore. 1993. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene 8: 1943-1956.
27. Kawai, S., S. Takeshita, M. Okazaki, R. Kikuno, A. Kudo, and E. Amann. 1994. Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J. Biochem. 115: 641-643.
28. Kharbanda, S., R. Ren, P. Pandey, T.D. Shafman, S.M. Feller, R.R. Weichselbaum, and D.W. Kufe. 1995. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785-788.
29. Kipreos, E.T. and J.Y.J. Wang. 1990. Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science 248: 217-220.
30. _. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256: 382-385.
31. Konopka, J.B. and O.N. Witte. 1985. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol. 5: 3116-3123.
32. Liu, Z.-G., R. Baskaran, E.T. Lea-Chou, L.D. Wood, Y. Chen, M. Karin, and J.Y.J. Wang. 1996. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276.
33. Lugo, T.G., A. Pendergast, A.J. Muller, and O.N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcrabl oncogene products. Science 247: 1079-1082.
34. Mayer, B.J. and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14: 2883-2894.
35. Mayer, B,J., P.K. Jackson, R.A. Van Etten, and D. Baltimore. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol. 12: 609-618.
36. McWhirter, J.R. and J.Y.J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of the Philadelphia chromosome-positive leukemias. EMBO J. 12: 1533-1546.
37. McWhirter, J.R., D.L. Galasso, and J.Y.J. Wang. 1993. A coiledcoil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13: 7587-7595.
38. Mitelman, F. 1994. Catalog of chromosome aberrations in cancer. Wiley-Liss, New York, NY.
39. Nemoto, Y., T. Yamamoto, S. Takada, Y. Matsui, and M. Obinata. 1990. Antisense RNA of the latent period gene (MER5) inhibits the differentiation of murine erythroleukemia cells. Gene 91: 261-265.
40. Pendergast, A.M., J.A. Traugh, and O.N. Witte. 1987. Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation. Mol. Cell. Biol. 7: 4280-4289.
41. Pendergast, A.M., A.J. Muller, M.H. Havelik, R. Clark, F. Mc-Cormick, and O.N. Witte. 1991a. Evidence for regulation of the human ABL tyrosine kinase by cellular inhibitor. Proc. Natl. Acad. Sci 88: 5927-5931.
42. Pendergast, A.M., A.J. Muller, M.H. Havlik, Y. Maru, and O.N. Witte. 1991b. BCR sequences esential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66: 161-171.
43. Pendergast, A.M., M.L. Gishizky, M.H. Havlik, and O.N. Witte. 1993. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence. Mol Cell. Biol 13: 1728-1736.
44. Prosperi, M.T., D. Ferbus, I. Karczinski, and G. Goubin. 1993. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268: 11050-11056.
45. Prosperi, M.T., F. Apiou, B. Dutrillaux, and G. Goubin. 1994. Organization and chromosomal assignment of two human PAG gene loci: PAGA encoding a functional gene and PAGB a processed pseudogene. Genomics 19: 236-241.
46. Ren, R., B.J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161.
47. Ren, R., S.Y. Zheng, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes & Dev. 8: 783-795.
48. Rickles, R.J., M.C. Botfield, Z. Weng, J.A. Taylor, O.M. Green, J.S. Brugge, and M.J. Zoller. 1994. Identification of Src, Fyn, PI3K and Abl SH3 domain ligands using phage display. EMBO J. 13: 5598-5604.
49. Rickles, R.J., M.C. Botfield, X.M. Zhou, P.A. Henry, J.S. Brugge, and M.J. Zoller. 1995. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl. Acad. Sci. 92: 10909-10913.
50. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382: 325-331.
51. Sawyers, C.L., J.L. McLaughlin, A. Goga, M. Havlik, and O. Witte. 1994. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77: 121-131.
52. m1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165-1176.
53. Sefton, B.M., T. Hunter, and W.C. Raschke. 1981. Evidence that the Abelson virus protein functions in vivo as a protein kinase that phosphorylates tyrosine. Proc. Natl. Acad. Sci. 78: 1552-1556.
54. Seidel-Dugan, C., B.E. Meyer, S.M. Thomas, and J.S. Brugge. 1992. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12: 1835-1845.
55. Shau, H., L.H. Butterfield, R. Chiu, and A. Kim. 1994. Cloning and sequence analysis of candidate human natural killerenhancing factor genes. Immunogenetics 40: 129-134.
56. Shi, Y., K. Alin, and S.P. Goff. 1995. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes &. Dev. 9: 2583-2597.
57. Sicheri, F., I. Moarefi, and J. Kuriyan. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609.
58. Sies, H. 1993. Strategies of antioxidant defense. Eur. J. Biochem. 215: 213-219.
59. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65: 1153-1164.
60. Van Etten, R.A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58: 669-678.
61. Van Etten, R.A., P.K. Jackson, D. Baltimore, M.C. Sanders, P.T. Matsudaira, and P.A. Janmey. 1994. The C-terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124: 325-340.
62. Van Etten, R.A., J. Debnath, H. Zhou, and J.M. Casasnovas. 1995. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10: 1977-1988.
63. Wang, J.Y.J., F. Ledley, S. Goff, R. Lee, Y. Groner, and D. Baltimore. 1984. The mouse c-abl locus: Molecular cloning and characterization. Cell 36: 349-356.
64. Welch, P.J. and J.Y.J. Wang. 1995. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes & Dev. 9:31-46.
65. Wen, S.-T., P.K. Jackson, and R.A. Van Etten. 1996. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals, and requires the p53 and Rb tumor suppressor gene products. EMBO J 15: 1583-1595.
66. Wilson, I.A., H.L. Niman, R.A. Houghten, A.R. Cherenson, M.L. Connolly, and R.A. Lerner. 1984. The structure of an antigenic determinant in a protein. Cell 37: 767-778.
67. Witte, O.N., A. Ponticelli, A. Gifford, D. Baltimore, N. Rosenberg, and J. Elder. 1981. Phosphorylation of the abelson murine leukemia virus transforming protein. J. Virol. 39: 870-878.
68. Xu, W., S.C. Harrison, and M.J. Eck. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595-602.
69. Yamamoto, T., Y. Matsui, S. Natori, and M. Obinata. 1989. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80: 337-343.
70. Yu, H., J.K. Chen, S. Feng, D.C. Dalgarno, A.W. Brauer, and S.L. Schreiber. 1994. Structural basis for the binding of prolinerich peptides to SH3 domains. Cell 76: 933-945.
71. Yuan, Z.-M., Y. Huang, Y. Whang, C. Sawyers, R. Weichselbaum, S. Kharbanda, and D. Kufe. 1996. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382: 272-274.
72. Yuan, Z.M., Y. Huang, T. Ishiko, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1997. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci 94: 1437-1440.
73. Zervos, A.S., J. Gyuris, and R. Brent. 1993. Mxi1 , a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232.
74. Zhu, J. and S.K. Shore. 1996. c-Abl tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein. Mol. Cell. Biol. 16: 7054-7062.